- Home
- CREV vs KTTA Comparison
CREV vs KTTA Comparison
Compare CREV & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- KTTA
- Stock Information
- Founded
- CREV 2007
- KTTA 2020
- Country
- CREV Australia
- KTTA United States
- Employees
- CREV N/A
- KTTA N/A
- Industry
- CREV
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- KTTA Health Care
- Exchange
- CREV Nasdaq
- KTTA Nasdaq
- Market Cap
- CREV 7.0M
- KTTA 5.7M
- IPO Year
- CREV N/A
- KTTA 2021
- Fundamental
- Price
- CREV $2.50
- KTTA $0.71
- Analyst Decision
- CREV
- KTTA
- Analyst Count
- CREV 0
- KTTA 0
- Target Price
- CREV N/A
- KTTA N/A
- AVG Volume (30 Days)
- CREV 118.8K
- KTTA 91.7K
- Earning Date
- CREV 01-01-0001
- KTTA 11-13-2025
- Dividend Yield
- CREV N/A
- KTTA N/A
- EPS Growth
- CREV N/A
- KTTA N/A
- EPS
- CREV N/A
- KTTA N/A
- Revenue
- CREV $47,677,475.00
- KTTA N/A
- Revenue This Year
- CREV $40.32
- KTTA N/A
- Revenue Next Year
- CREV N/A
- KTTA N/A
- P/E Ratio
- CREV N/A
- KTTA N/A
- Revenue Growth
- CREV 86.77
- KTTA N/A
- 52 Week Low
- CREV $2.00
- KTTA $0.65
- 52 Week High
- CREV $12.75
- KTTA $3.85
- Technical
- Relative Strength Index (RSI)
- CREV 34.75
- KTTA 49.36
- Support Level
- CREV $2.33
- KTTA $0.66
- Resistance Level
- CREV $4.58
- KTTA $0.75
- Average True Range (ATR)
- CREV 0.60
- KTTA 0.06
- MACD
- CREV -0.25
- KTTA -0.00
- Stochastic Oscillator
- CREV 11.26
- KTTA 44.33
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).